Download full report with analyst certification and important disclosures
May 11 2022, 07:10 IST/BST
Uniphar
Trading in-line, Navi pushed to a H2 22 close
- Sectors : Pharma and healthcare
- Companies : Uniphar
DAVY VIEW
Uniphar’s short trading update this morning points to strong execution year-to-date and continued confidence in the group’s organic outlook for FY 22. The later closing of the Navi deal leads to a minor adjustment to FY 22 EPS (-2%), and we leave our FY 23 numbers unchanged. 2022 is shaping up to be another year of excellent organic profit growth for Uniphar. Following 12 transactions since IPO in 2019, we also remain confident in the group’s ability to augment this growth with further M&A.
